Turvill J L, Mourad F H, Farthing M J
Digestive Diseases Research Centre, St Bartholomew's and the Royal London School of Medicine and Dentistry, Turner Street, London E1 2AD, UK.
Gut. 1999 Jan;44(1):33-9. doi: 10.1136/gut.44.1.33.
Cholera toxin causes small intestinal hypersecretion by inducing a coordinated response from enterocytes, enterochromaffin cells, enteric neurones, and the vascular supply. Nitric oxide has been implicated in the function of these separate components.
To explore the role of nitric oxide in the totality of cholera toxin induced secretion in vivo.
One group of adult male Wistar rats was treated with the nitric oxide synthase inhibitors NG-nitro-L-arginine methyl ester (L-NAME; subcutaneously or intraluminally), NG-methyl-L-arginine (L-NMA), or 7-nitroindazole. A second group of rats was treated with L-arginine (intraperitoneally or intraluminally) or D-arginine. The small intestine was isolated between two cannulae and instilled with 75 microg cholera toxin or saline for two hours. Small intestinal perfusion of a plasma electrolyte solution containing [14C]-PEG was undertaken to determine net water and electrolyte movement. After the experiment macroscopic and microscopic intestinal appearances were noted and jejunal 5-hydroxytryptamine concentrations were determined.
Both L-arginine and L-NAME induced secretion in the basal state, but only when administered intraluminally. Systemically applied L-NAME caused a dose dependent reduction in cholera toxin induced secretion. This was paralleled by L-NMA but not by 7-nitroindazole or by intraluminally applied L-NAME. Systemically applied L-NAME caused notable cyanosis of the intestine, consistent with mesenteric ischaemia, but no microscopic abnormalities. Systemically applied L-arginine but not D-arginine also reduced cholera toxin induced secretion and inhibited 5-hydroxytryptamine release.
Nitric oxide has a duality of roles in cholera toxin induced secretion, acting both as an absorbagogue and a secretagogue. Its mechanisms of action include the maintenance of mucosal perfusion and enterochromaffin cell stabilisation.
霍乱毒素通过诱导肠上皮细胞、肠嗜铬细胞、肠神经元和血管供应的协同反应,导致小肠分泌过多。一氧化氮与这些不同成分的功能有关。
探讨一氧化氮在霍乱毒素诱导的体内分泌整体过程中的作用。
一组成年雄性Wistar大鼠用一氧化氮合酶抑制剂NG-硝基-L-精氨酸甲酯(L-NAME;皮下或腔内给药)、NG-甲基-L-精氨酸(L-NMA)或7-硝基吲唑处理。另一组大鼠用L-精氨酸(腹腔内或腔内给药)或D-精氨酸处理。在两个插管之间分离小肠,并用75微克霍乱毒素或生理盐水灌注两小时。进行含有[14C]-PEG的血浆电解质溶液的小肠灌注,以确定水和电解质的净移动。实验后,记录小肠的宏观和微观外观,并测定空肠5-羟色胺浓度。
L-精氨酸和L-NAME在基础状态下均诱导分泌,但仅在腔内给药时。全身应用L-NAME导致霍乱毒素诱导的分泌呈剂量依赖性减少。L-NMA也有类似情况,但7-硝基吲唑或腔内应用L-NAME则没有。全身应用L-NAME导致小肠明显发绀,与肠系膜缺血一致,但无微观异常。全身应用L-精氨酸而非D-精氨酸也减少了霍乱毒素诱导的分泌并抑制了5-羟色胺的释放。
一氧化氮在霍乱毒素诱导的分泌中具有双重作用,既作为吸收促进剂又作为分泌促进剂。其作用机制包括维持黏膜灌注和稳定肠嗜铬细胞。